Abiopharma

Investors Title Company Announces Second Quarter 2026 Results

Neptune Flood Research Group Examines a Decade of Storms, Warns 2025s Quiet Hurricane Season Isnt a Trend

HCTIs Teyame Delivers a Full Year of Client Revenue in Six Months; €2 Million in Target

General Announcement: FINAL AWARDS IN RESPECT OF ARBITRATION BETWEEN RAFFLES K12 SDN BHD AND PEMBINAAN MITRAJAYA SDN BHD

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress

Financial Statements and Related Announcement: Second Quarter and/ or Half Yearly Results

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

A New Press Release from Theriva Biologics, Inc.

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

Regency Centers Declares Quarterly Dividends